Searching journal content for articles similar to Kim et al. 28 (3): 374.

Displaying results 1-9 of 9
For checked items
  1. ...: In this window In a new window Figure 1. Joint analysis of several CRISPR/Cas9 knockout screens. (A) JACKS inferred decomposition of median-normalized log2 fold change (heatmap) for six gRNAs targeting the KRAS gene (y-axis, GeCKOv2 library) in 25 cancer cell lines from Aguirre et al. (2016) (x...
  2. ...Technology, #07922) (see Supplemental Methods; Supplemental Table S11).Preparation of vectors for transfectionTwo vectors were purchased: (1) CMV-rtTA-HygR vector (Addgene, #102423) and (2) CRISPR-Cas9 vectors containing gRNA sequence for TP53 (Addgene, #121917). To generate the pPB-CMVmin-APOBEC (A3A or A3B...
  3. ...representation of porcine EML4–ALK rearrangements induced by CRISPR-Cas9. EML4-sgRNA and ALK-sgRNA (red) were designed to target the mutation sites of the porcine EML4 gene intron 14 and porcine ALK gene intron 13. PCR primers are indicated (primers A, B, C, and D). (B) PCRs were performed to analyze ALK–EML4...
  4. ...aimed to characterize the pathogenic implication of TXN deregulation in MM cells. TXN inactivation using the CRISPR-Cas9 strategy in MM cell lines (Fig. 3C,D; Supplemental Figs. S12B,C, S13) led to a significant reduction of growth rate as compared to control cells (Fig. 3E; Supplemental Fig. S12D...
  5. ...DNA, followed by size selection. Like the CRISPR-Cas9 approach (Nachmanson et al. 2018), this also enables the selection of predetermined target fragments, achieving also a low number of off-targets. Further enrichment of targeted regions is performed by two rounds of hybridization capture followed...
  6. ...in these samples (two-sided Fisher's exact test, P-value = 9.9 × 10−21), with only four fusions (2× FGFR2-COL14A1, 1× DNAJB1-PRKACA, 1× KANK1-NTRK3) being found in KRAS mutant tumors (Supplemental Table S5). In 79 tumors, we detected neither a KRAS mutation nor a driving fusion. To rule out the possibility that we...
  7. .... For this purpose, we combined CRISPR-Cas9 technology with the DNA-damage responsive system to investigate the expression of TP53-regulated lncRNAs, following by ribosome profiles and mass spectrometry (MS) methods to explore the translational potentials of lncRNAs in adriamycin (ADR)-treated HepG2 cells...
  8. ...–phenotype relationship describes how genetic variations induce biological change (Manolio et al. 2009). Experimental screens tracking the effect of these variations include RNA interference (RNAi) (Boutros and Ahringer 2008), CRISPR-Cas9 knockouts (Mali et al. 2013; Koike-Yusa et al. 2014; Wang et al. 2014b; Hart et al...
  9. .... Such screens, if sufficiently unbiased, could in theory capture the entire breadth of genetic resistance mechanisms for any drug. Recent studies have demonstrated the power of both -wide gain- and loss-offunction screens using CRISPR/Cas9, lentiviral shRNA, and largescale open-reading frame technologies...
For checked items

Preprint Server